Author

Mai Arai

Observed name: Mai ARAI

Institution: Carna Biosciences (Japan)

Observed institutions: SHOWA Medical University, SHOWA Medical University Northern Yokohama Hospital, Carna Biosciences (Japan), Tokushima University

ORCID: 0009-0001-3317-5347

Observed ORCID: 0009-0001-3317-5347

OpenAlex ID: A5079200004

Chemistry, Properties, and in Vitro and in Vivo Applications of 2′‐O‐Methoxyethyl‐4′‐thioRNA, a Novel Hybrid Type of Chemically Modified RNA

2014 · Yota Saito, Yosuke Hashimoto, et al. · ChemBioChem · 17

Design and synthesis of novel thiazole-derivatives as potent ALK5 inhibitors

2024 · Mai Arai, Mitsuharu Hanada, et al. · Bioorganic & Medicinal Chemistry Letters · 4

Abstract 5336: Discovery of a novel activin receptor-like kinases (ALKs) inhibitor targeting TGF-β signaling pathways

2023 · Mai Arai, Mitsuharu Hanada, et al. · Cancer Research · 3

Discovery of HM-279, a Potent Inhibitor of ALK5 for Improving Therapeutic Efficacy of Cancer Immunotherapy

2025 · Mai Arai, Mitsuharu Hanada, et al. · Journal of Medicinal Chemistry · 2

Familial Mediterranean Fever E148Q/P369S/R408Q Exon 3 Variant with Severe Abdominal Pain and PFAPA-Like Symptoms

2016 · Makiko Tajika, Mai Arai · Journal of Clinical Case Reports · 2

Remarkable effectiveness of tocilizumab in familial Mediterranean fever exon 3 variant with severe abdominal pain and PFAPA-like symptoms: a child case report and review of the literature

2019 · Makiko Tajika, Yusuke Takeuchi, et al. · Modern Rheumatology Case Reports

The Case of Three Infants in Whom Streptococcus pneumoniae was Isolated from Their Blood After Inoculation with 7-valent Pneumococcal Conjugate Vaccine ―Importance of the Investigation of Streptococcus pneumoniae Serotype―

2014 · Kazuhiko MATSUHASHI, Mai ARAI, et al. · Kansenshogaku zasshi

Works count: 7

Citation count: 28

H-index: 3

I10-index: 1